| Metric | Value ($ M) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 8.06 | 8.1% | 13.4% |
| Total Income | 8.06 | 8.1% | 13.4% |
| Expenditure | 11.38 | 5.0% | 34.2% |
| PBT | -3.32 | 60.4% | 500.0% |
| Net Profit | -2.51 | 57.9% | 498.4% |
| OPM | — | ||
| NPM | -31.17% | 13.06pp | 37.94pp |
| EPS | -0.04 | 33.3% | 500.0% |
Health In Tech Reports Q2 2026 Financial Results
14 Aug 2026 · 14 Aug, 2:16 am
Summary
Health In Tech reported second quarter 2026 revenue of $8.1 million, down from $9.3 million in the prior year quarter, and first-half 2026 revenue of $16.8 million, down from $17.3 million. The company experienced a net loss of $2.5 million in Q2 2026, a shift from a net income of $0.6 million in Q2 2025. Despite the revenue decline, distribution partners grew by 19.9% year-over-year. Management reaffirmed its full-year 2026 revenue guidance of $45 million to $50 million, citing investments in sales, marketing, and product innovation.
Key Highlights
- 1
Health In Tech reported Q2 2026 revenue of $8.1 million, a decrease from $9.3 million in Q2 2025.
- 2
First-half 2026 revenue was $16.8 million, compared to $17.3 million in the prior year period.
- 3
Distribution Partners, including brokers, TPAs, and agencies, reached 933 as of June 30, 2026, an increase of 19.9% year over year.
- 4
Net loss for Q2 2026 was $2.5 million, or $(0.04) per diluted share, compared to a net income of $0.6 million, or $0.01 per diluted share, in Q2 2025.
- 5
First-half 2026 net loss was $4.1 million, or $(0.07) per diluted share, compared to a net income of $1.1 million, or $0.02 per diluted share, in first-half 2025.
- 6
Adjusted EBITDA was $(1.3) million for Q2 2026 and $(2.6) million for first-half 2026, reflecting continued investment in distribution, technology, and product development.
- 7
The Company is reaffirming its full-year 2026 revenue guidance of $45 million to $50 million.
Management Comments
Tim Johnson
We continued to execute against our long-term growth strategy during the quarter by investing in sales, marketing, and key talent, supported in part by the capital raised through our recent PIPE financing. These investments are designed to expand our distribution network, accelerate product innovation, and strengthen our execution capabilities. Our contracted book of business continued to grow, providing greater visibility into future revenue. We believe Contracted Revenue and Pipeline Revenue are meaningful operating metrics that complement our GAAP financial results by illustrating the strength of our sales pipeline, the pace of customer conversion, and our expected revenue trajectory. We also made meaningful progress on several strategic initiatives that we believe position the Company for its next phase of growth. During the quarter, we contractually secured our first employer group for the Three-Year Rate Stabilization Program, a differentiated solution designed to provide employers with greater predictability in stop-loss pricing over a multi-year period. This represents an important milestone as we advance toward the program’s anticipated launch in the capital markets. In parallel, we are engaged with several high-profile governmental organizations that are evaluating participation in the program, and we expect to provide additional updates in the coming months. As we execute on our strategic roadmap, we remain on track to launch HitRix, our next-generation marketplace platform, in the second half of 2026. While our current eDIYBS platform has transformed AI-enabled underwriting through bindable stop-loss quoting and customized plan design, HitRix expands the application of AI across the entire self-funded stop-loss insurance ecosystem. The platform leverages advanced AI-powered document intelligence to automate data extraction across multiple document types, enable intelligent plan comparisons, and facilitate an integrated competitive bidding process within a unified digital marketplace. By connecting a broad network of brokers, carriers, TPAs, and employer groups, HitRix is designed to increase market transparency, expand access to competitive stop-loss solutions, streamline the placement process, and deliver better outcomes for all participants across the self-funded insurance value chain.
Informational and educational content only. Not investment advice.